Phio Pharmaceuticals (PHIO) Asset Utilization Ratio (2013 - 2019)
Phio Pharmaceuticals' (PHIO) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2019, down 83.93% YoY from 0.01 in Q4 2018, and up 22.46% on a QoQ basis from 0.0 in Q3 2019.
Phio Pharmaceuticals (PHIO) Asset Utilization Ratio (2013 - 2019) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 7 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2019.
- Quarterly Asset Utilization Ratio fell 83.93% year-over-year to 0.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was 0.0 (down 83.93% YoY) and the FY2019 annual result came in at 0.0, down 87.35% from the prior year.
- Asset Utilization Ratio climbed to 0.0 in Q4 2019, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.03 in Q3 2018 to a low of 0.0 in Q1 2016.
- A 5-year average of 0.01 and a median of 0.0 in 2015 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2018 — Asset Utilization Ratio soared 1201.38% — and 2019, when it slumped 93.91%.
- Tracing PHIO's Asset Utilization Ratio over 5 years: stood at 0.0 in 2015, then dropped by 27.14% to 0.0 in 2016, then jumped by 108.69% to 0.0 in 2017, then soared by 232.88% to 0.01 in 2018, then sank by 83.93% to 0.0 in 2019.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q4 2019), 0.0 (Q3 2019), and 0.01 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.13 |
| 10 | Phio Pharmaceuticals | 13.94 Mn | 13.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.00 |
| Sep 30, 2019 | 0.00 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.03 |
| Jun 30, 2018 | 0.02 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.00 |
| Jun 30, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | 0.01 |
| Mar 31, 2015 | 0.01 |
| Dec 31, 2014 | 0.01 |
| Sep 30, 2014 | 0.01 |